CleanCap® FLuc mRNA (5moU)
Description
The FLuc mRNA expresses a luciferase protein, originally isolated from the firefly, Photinus pyralis. FLuc is commonly used in mammalian cell culture to measure both gene expression and cell viability. It emits bioluminescence in the presence of the substrate, luciferin.
This mRNA is capped using CleanCap® Reagent AG, TriLink's patented co-transciptional capping technology, which results in the naturally occurring Cap-1 structure with >95% capping efficiency. It is manufactured using TriLink's CleanScript™ method*, polyadenylated, modified with 5-methoxyuridine, and optimized for mammalian systems. It mimics a fully processed mature mRNA.
CleanCap® Reagent AG produces a base-modified Cap-1 mRNA, which shows superior in vivo activity compared to Cap-0 mRNA produced by legacy capping methods such as mCap or anti-reverse cap analog (ARCA).
5-methoxyuridine is a modified uridine that can reduce immunogenic response and enhance translational efficiency of mRNAs. These properties can result in safer mRNA and increased protein expression.
CleanScript™ method is TriLink's proprietary in vitro transcription process that is optimized to minimize dsRNA formation and increase mRNA activity in vivo.
*Starting April 30th, 2024
Product details
Catalog No | L-7202 |
Purity | Passes Agarose Gel Mobility |
Concentration | 1.0 mg/mL |
Buffer | 1 mM Sodium Citrate pH 6.4 |
Recommended Storage | At or below -40°C |
Application | Reporter Genes |
Base Composition | Fully substituted with 5-Methoxy-U |
Brand | CleanCap |
Cap | AG Start |
Composition | Fully substituted with 5-Methoxy-U |
Conversion Factor | 40 µg/OD₂₆₀ |
length | 1922 nucleotides |
Phosphatase Treated | True |
Shipping Temp | Frozen |
Technical documents
- Safety Data Sheet Look-up open_in_new
- L-7202 Product Insert open_in_new
Certificate of analysis
- Certificate of Analysis (CoA) open_in_new
Intellectual property
Products are for research use only, not for use in diagnostic or therapeutic procedures or for use in humans. Products are not for resale without express written permission from TriLink No license under any patent or other intellectual property right of TriLink or its licensors is granted or implied by the purchase unless otherwise provided in writing.
CleanCap capping technology
For Research Use Only. Not for use in humans. Not for use in diagnostic or therapeutic purposes. For additional licensing restrictions, please see the license agreement at trilinkbiotech.com/cleancap-research-license. Patents and patent pending, see trilinkbiotech.com/legal-notices.
Related products
-
CleanCap® M6 FLuc mRNA (N1MePsU) L-8102open_in_new
-
CleanCap® FLuc mRNA L-7602open_in_new